Rang	Name	Position
1	Dr. Sharon Mates Ph.D.	Co-Founder, Chairman & CEO
2	Mr. Michael I. Halstead J.D.	President
3	Mr. Sanjeev Narula	Executive VP, CFO & Treasurer
4	Dr. Suresh K. Durgam M.D.	Executive VP & Chief Medical Officer
5	Mr. Mark Neumann	EVP & Chief Commercial Officer
6	Dr. Robert E. Davis Ph.D.	Senior VP & Chief Scientific Officer
7	Mr. Juan Fernando Sanchez M.D.	Vice President of Corporate Communications & Investor Relations
8	Ms. Karen Patruno Sheehy Esq.	Senior VP & Chief Compliance Officer
9	John P. Condon	Senior VP, General Counsel & Secretary
10	Dr. Michael Olchaskey Pharm.D.	Senior VP & Head of Regulatory Affairs

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Group Inc	8,95%	1,26 Mrd. USD
2	BlackRock Inc	8,23%	1,16 Mrd. USD
3	Pentwater Capital Management LP	4,88%	0,69 Mrd. USD
4	Davidson Kempner Capital Management LP	3,28%	0,46 Mrd. USD
5	NORGES BANK	3,02%	0,42 Mrd. USD
6	UBS O'Connor LLC	2,91%	0,41 Mrd. USD
7	Amvescap Plc.	2,89%	0,41 Mrd. USD
8	Farallon Capital Management, L.L.C.	2,87%	0,40 Mrd. USD
9	FMR Inc	2,50%	0,35 Mrd. USD
10	Balyasny Asset Management LLC	2,12%	0,30 Mrd. USD
11	Deep Track Capital, LP	1,88%	0,26 Mrd. USD
12	Geode Capital Management, LLC	1,72%	0,24 Mrd. USD
13	Bank of America Corp	1,71%	0,24 Mrd. USD
14	State Street Corp	1,68%	0,24 Mrd. USD
15	Weiss Asset Management LP	1,54%	0,22 Mrd. USD
16	Glazer Capital, LLC	1,49%	0,21 Mrd. USD
17	Goldman Sachs Group Inc	1,39%	0,20 Mrd. USD
18	Morgan Stanley - Brokerage Accounts	1,32%	0,19 Mrd. USD
19	VOLORIDGE INVESTMENT MANAGEMENT, LLC	1,03%	0,14 Mrd. USD
20	Test Hedge Fund Mgmt	0,99%	0,14 Mrd. USD